President Donald Trump announced that his administration would tackle rising drug costs in the United States by establishing “most favored nation” pricing which would base the U.S. prices of pharmaceuticals on the lowest prices paid by other foreign nations.

U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with what other countries pay that analysts and legal experts said would be difficult to implement.